Pharmacotherapy of Parkinson`s disease

A tétel rövid nézete
dc.contributor.advisorSzentmiklósi, József András
dc.contributor.advisordeptDepartment of Pharmacology and Pharmacotherapy (Debrecen)hu_HU
dc.contributor.authorMohammad ali, Bahmaei
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentPórszász, Róbert
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház Aneszteziológiai és Intenziv Therápiás Osztályhu_HU
dc.date.accessioned2017-01-05T13:46:13Z
dc.date.available2017-01-05T13:46:13Z
dc.date.created2016
dc.description.abstractThere are several drugs which are effective in symptomatic management of Parkinson`s disease However there is no definitive pharmaceutical therapy for Parkinson`s disease. Drugs used in symptomatic management of Parkinson`s disease include : dopaminergic agents such as levodopa/carbidopa and dopamine-agonists (ropinirole, pramipexole), monoamine oxidase type B inhibitors (selegiline, rasagiline), catecholo-methyltransferase inhibitors (entacapone, tolcapone), anticholinergic agents, amantadine plus alternative therapies and investigational agents.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent44hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/233607
dc.language.isoenhu_HU
dc.subjectPharmacotherapyhu_HU
dc.subjectParkinson`s disease
dc.subjectdopaminergic agents
dc.subjectmonoamine oxidase type B inhibitors
dc.subjectcatecholo-methyltransferase
dc.subjectFreezing of gait
dc.subjectwearing-off
dc.subjectdystonias
dc.subjectdyskinesias
dc.subjectnonmotor complications
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titlePharmacotherapy of Parkinson`s diseasehu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)